BrainStorm Cell Therapeutics
BCLI
#10405
Rank
โ‚ฌ5.49 M
Marketcap
0,50ย โ‚ฌ
Share price
4.46%
Change (1 day)
-67.39%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -โ‚ฌ10.4 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ9.91 Million, an increase over its 2023 earnings that were of -โ‚ฌ14.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ10.4 Million5.01%
2024 -โ‚ฌ9.91 Million-32.39%
2023 -โ‚ฌ14.65 Million-29.18%
2022 -โ‚ฌ20.69 Million-0.74%
2021 -โ‚ฌ20.84 Million-23.12%
2020 -โ‚ฌ27.11 Million36.8%
2019 -โ‚ฌ19.82 Million66.71%
2018 -โ‚ฌ11.89 Million181.66%
2017 -โ‚ฌ4.22 Million-0.6%
2016 -โ‚ฌ4.25 Million-41.31%
2015 -โ‚ฌ7.24 Million-8.22%
2014 -โ‚ฌ7.88 Million89.74%
2013 -โ‚ฌ4.16 Million42.27%
2012 -โ‚ฌ2.92 Million-12.45%
2011 -โ‚ฌ3.34 Million63.04%
2010 -โ‚ฌ2.05 Million35.52%
2009 -โ‚ฌ1.51 Million-48.99%
2008 -โ‚ฌ2.96 Million-44.39%
2007 -โ‚ฌ5.32 Million
2005 -โ‚ฌ2.76 Million-91.44%
2004 -โ‚ฌ32.19 Million94007.62%
2003 -โ‚ฌ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.42 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.65 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚ฌ0.68 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.62 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.6 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.22 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA